Editas Medicine, Inc. (NASDAQ:EDIT) just released its quarterly report and things are looking bullish. Revenues of US$7.5m beat estimates by a substantial 53% margin. Unfortunately, Editas Medicine ...
Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback